Measles outbreak in Semuto Subcounty, Nakaseke District, Uganda, June-August 2021.

Case–control studies Disease outbreaks Measles Risk factors Uganda Vaccine coverage

Journal

IJID regions
ISSN: 2772-7076
Titre abrégé: IJID Reg
Pays: England
ID NLM: 9918418183106676

Informations de publication

Date de publication:
Dec 2022
Historique:
received: 04 08 2022
revised: 30 08 2022
accepted: 31 08 2022
entrez: 3 10 2022
pubmed: 4 10 2022
medline: 4 10 2022
Statut: epublish

Résumé

Semuto Subcounty reported rubella/measles outbreaks in January 2020 and June-August 2021. This study investigated the outbreak in 2021 to determine the scope, and the factors associated with transmission. A probable case was defined as a resident of Semuto Subcounty with acute onset of fever and a generalized maculopapular rash with either cough/cold or red eyes from 1 June to 31 August 2021. A confirmed case was defined as a probable case with a blood sample positive for measles-specific IgM. A village-matched case-control study was conducted with 30 cases and 122 controls (1:4 ratio). A control was defined as an individual aged 6 months-9 years, sampled at random, with no signs or symptoms of measles from 1 June to 31 August 2021, residing in the same village as the matched case. Adjusted Mantel-Haenszel odds ratios (OR Of the 30 cases (27 probable and three confirmed), 16 (53%) were male. The subcounty attack rate (AR) was 3.2/1000. Children aged 5-9 years were the most affected (AR 5.0/1000). Twenty-two (79%) cases and 116 (97%) controls had ever received measles vaccine (OR Socializing/congregating at water collection points and community playgrounds facilitated the transmission of measles in this outbreak.

Sections du résumé

Background UNASSIGNED
Semuto Subcounty reported rubella/measles outbreaks in January 2020 and June-August 2021. This study investigated the outbreak in 2021 to determine the scope, and the factors associated with transmission.
Methods UNASSIGNED
A probable case was defined as a resident of Semuto Subcounty with acute onset of fever and a generalized maculopapular rash with either cough/cold or red eyes from 1 June to 31 August 2021. A confirmed case was defined as a probable case with a blood sample positive for measles-specific IgM. A village-matched case-control study was conducted with 30 cases and 122 controls (1:4 ratio). A control was defined as an individual aged 6 months-9 years, sampled at random, with no signs or symptoms of measles from 1 June to 31 August 2021, residing in the same village as the matched case. Adjusted Mantel-Haenszel odds ratios (OR
Results UNASSIGNED
Of the 30 cases (27 probable and three confirmed), 16 (53%) were male. The subcounty attack rate (AR) was 3.2/1000. Children aged 5-9 years were the most affected (AR 5.0/1000). Twenty-two (79%) cases and 116 (97%) controls had ever received measles vaccine (OR
Conclusions UNASSIGNED
Socializing/congregating at water collection points and community playgrounds facilitated the transmission of measles in this outbreak.

Identifiants

pubmed: 36188443
doi: 10.1016/j.ijregi.2022.08.017
pii: S2772-7076(22)00112-6
pmc: PMC9515593
doi:

Types de publication

Journal Article

Langues

eng

Pagination

44-50

Informations de copyright

© 2022 The Author(s).

Références

Indian J Med Sci. 2004 Feb;58(2):47-53
pubmed: 14993716
J Infect Dis. 2010 Jun 1;201(11):1607-10
pubmed: 20402594
J Infect Dis. 2011 Jul;204 Suppl 1:S471-5
pubmed: 21666202
J Infect Dis. 1986 Nov;154(5):858-63
pubmed: 3772165
Euro Surveill. 2008 Feb 21;13(8):
pubmed: 18445414
Bull World Health Organ. 2002;80(10):776-82
pubmed: 12471397
Curr Top Microbiol Immunol. 1995;191:117-34
pubmed: 7789155
Bull World Health Organ. 2000;78(8):949
pubmed: 10994276
N Engl J Med. 1989 Jan 12;320(2):75-81
pubmed: 2911293
BMC Infect Dis. 2018 Aug 20;18(1):412
pubmed: 30126362
Lancet Infect Dis. 2009 May;9(5):291-300
pubmed: 19393959
Bull World Health Organ. 2009 Feb;87(2):108-15
pubmed: 19274362
MMWR Morb Mortal Wkly Rep. 2006 May 12;55(18):511-5
pubmed: 16691182
BMC Infect Dis. 2018 Jan 8;18(1):21
pubmed: 29310585
Pediatrics. 1985 Apr;75(4):676-83
pubmed: 3982900
Vaccine. 2008 Dec 9;26(52):6980-5
pubmed: 18805455
Pediatrics. 2005 Dec;116(6):1287-91
pubmed: 16322148
Wkly Epidemiol Rec. 2009 Aug 28;84(35):349-60
pubmed: 19714924
Clin Infect Dis. 2006 Feb 1;42(3):315-9
pubmed: 16392073
Curr Opin Virol. 2020 Feb;40:48-54
pubmed: 32634672
Pan Afr Med J. 2017 Jun 09;27(Suppl 2):9
pubmed: 28983397

Auteurs

Edirisa Juniour Nsubuga (EJ)

Uganda Public Health Fellowship Programme, Kampala, Uganda.

Job Morukileng (J)

Uganda Public Health Fellowship Programme, Kampala, Uganda.

Josephine Namayanja (J)

Uganda Public Health Fellowship Programme, Kampala, Uganda.

Daniel Kadobera (D)

Uganda Public Health Fellowship Programme, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Fred Nsubuga (F)

Uganda National Expanded Programme on Immunization, Ministry of Health, Kampala, Uganda.

Irene Byakatonda Kyamwine (IB)

Uganda Public Health Fellowship Programme, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Lilian Bulage (L)

Uganda Public Health Fellowship Programme, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Benon Kwesiga (B)

Uganda Public Health Fellowship Programme, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Alex Riolexus Ario (AR)

Uganda Public Health Fellowship Programme, Kampala, Uganda.
Uganda National Institute of Public Health, Kampala, Uganda.

Julie R Harris (JR)

United States Centers for Disease Control and Prevention, Kampala, Uganda.
Workforce and Institute Development Branch, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Classifications MeSH